It is an indole-3-acetic acid derivative that acts as a mitochondrial function enhancer and ATP production accelerator. It protects against mitochondrial dysfunction by binding to mitochondrial proteins (like mitofilin) and increasing ATP production. MA-5 is researched for treating mitochondrial diseases, kidney damage, and age-related hearing loss.

• Mechanism: Enhances ATP production and stabilizes mitochondrial membrane potential.

• ATP production accelerator, protects against neurological damage in ischemic stroke

• Function: Promotes mitophagy (removal of damaged mitochondria) and reduces ROS.

• Applications: Potential therapeutic for mitochondrial diseases, kidney ischemia-reperfusion injury, and neurodegeneration.

https://pmc.ncbi.nlm.nih.gov/articles/PMC5887257/
https://www.caymanchem.com/product/35702/mitochonic-acid-5#
https://pubmed.ncbi.nlm.nih.gov/26609120/
https://pubmed.ncbi.nlm.nih.gov/40339682/
https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2025.1541347/full#
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.911716/full#

It is new so studies are limited, although I am skeptical of many of them anyway. In a truly Peat fashion, MA-5 seems very promising, but it's too early to speak of safety. I have a sense about this one however, I have a feeling it will be very important.